US Patent Issued to 60 Degrees Pharmaceuticals on July 7 for "Methods for the treatment and prevention of lung infections caused by SARS-CoV-2 virus by administration of tafenoquine" (District Of Columbia Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,053, issued on July 7, was assigned to 60 Degrees Pharmaceuticals Inc. (Washington).

"Methods for the treatment and prevention of lung infections caused by SARS-CoV-2 virus by administration of tafenoquine" was invented by Geoffrey S. Dow (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for treating or preventing a lung infection, or related symptoms, caused by a virus using an effective amount of tafenoquine are disclosed. Methods and compositions for treating or preventing a lung infection in a human that is infected with SARS-CoV-2 using tafenoquine are disclosed. Kits including tafenoquine and means for testing f...